Achieve Life Sciences (ACHV) Stock: Buy, Sell, or Hold?
ACHV - Achieve Life Sciences, Inc.
$6.51
0.00 (0.00%)
▲
5d:
-7.0%
30d:
-19.83%
90d:
+5.51%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When ACHV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ACHV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ACHV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ACHV is currently trading at $6.51, which is considered oversold relative to its 30-day fair value range of $6.84 to $7.83.
Technical Outlook: Technically, ACHV is in a strong uptrend. Immediate support is located at $6.22, while resistance sits at $7.48.
Market Sentiment: ACHV scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.15 (+117.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACHV is in a strong uptrend. Immediate support is located at $6.22, while resistance sits at $7.48.
Market Sentiment: ACHV scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.15 (+117.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.84 -
$7.83
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 117.4% below Wall St target ($14.15)
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Trading Range Analysis
30-Day Trading Range
$6.84 -
$7.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.22
Resistance Level
$7.48
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.98
Wall Street Target
$14.15
(+117.4%)
Share & Embed Analysis
Last updated: October 22, 2026 8:28 AM ET
Data refreshes hourly during market hours. Next update: 9:28 AM
Data refreshes hourly during market hours. Next update: 9:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACHV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 54 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 58 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 59 HOLD |
|
CLYM
Climb Bio Inc |
STRONG BUY
15 analysts |
$28 | 67 BUY |
